Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Barbara Muzzatti, Nicoletta Cattaruzza, Marika Piccinin, Cristiana Flaiban, Giulia Agostinelli, Massimiliano Berretta & Maria Antonietta Annunziata. (2021) Cognitive function in long-term lymphoma survivors: relationship between subjective reports and objective assessments and with quality of life. Psychology, Health & Medicine 26:8, pages 968-979.
Read now
Read now
AnnaLynn M. Williams, Edwin van Wijngaarden, Christopher L. Seplaki, Charles E. Heckler, Miriam T. Weber, Paul M. Barr, Clive S. Zent & Michelle C. Janelsins. (2020) Cognitive function in patients with chronic lymphocytic leukemia: a cross-sectional study examining effects of disease and treatment. Leukemia & Lymphoma 61:7, pages 1627-1635.
Read now
Read now
Alessandro Allegra, Vanessa Innao, Giorgio Basile, Marta Pugliese, Andrea Gaetano Allegra, Nicolina Pulvirenti & Caterina Musolino. (2020) Post-chemotherapy cognitive impairment in hematological patients: current understanding of chemobrain in hematology. Expert Review of Hematology 13:4, pages 393-404.
Read now
Read now
Hans Wouters, Joke W. Baars & Sanne B. Schagen. (2016) Neurocognitive function of lymphoma patients after treatment with chemotherapy. Acta Oncologica 55:9-10, pages 1121-1125.
Read now
Read now
Articles from other publishers (47)
M. Skurlova, K. Holubova, L. Kleteckova, T. Kozak, H. Kubova, J. Horacek & K. Vales. (2023) Chemobrain in blood cancers: How chemotherapeutics interfere with the brain's structure and functionality, immune system, and metabolic functions. Medicinal Research Reviews 44:1, pages 5-22.
Crossref
Crossref
Jorge Gomez-Deza, Anastasia L. Slavutsky, Matthew Nebiyou & Claire E. Le Pichon. (2023) Local production of reactive oxygen species drives vincristine-induced axon degeneration. Cell Death & Disease 14:12.
Crossref
Crossref
Ding Quan Ng, Ivy Cheng, Claire Wang, Chia Jie Tan, Yi Long Toh, Yong Qin Koh, Yu Ke, Koon Mian Foo, Raymond J. Chan, Han Kiat Ho, Lita Chew, Mohamad Farid bin Harunal Rashid & Alexandre Chan. (2023) Brain-derived neurotrophic factor as a biomarker in cancer-related cognitive impairment among adolescent and young adult cancer patients. Scientific Reports 13:1.
Crossref
Crossref
Manal T. Usmani, Robert P. KrattliJr.Jr., Sanad M. El-Khatib, Anh C. D. Le, Sarah M. Smith, Janet E. Baulch, Ding Quan Ng, Munjal M. Acharya & Alexandre Chan. (2023) BDNF Augmentation Using Riluzole Reverses Doxorubicin-Induced Decline in Cognitive Function and Neurogenesis. Neurotherapeutics 20:3, pages 838-852.
Crossref
Crossref
Weixi Feng, Yanli Zhang, Shixin Ding, Sijia Chen, Tianqi Wang, Ze Wang, Ying Zou, Chengyu Sheng, Yan Chen, Yingting Pang, Charles Marshall, Jingping Shi, Maiken Nedergaard, Qian Li & Ming Xiao. (2023) B lymphocytes ameliorate Alzheimer’s disease-like neuropathology via interleukin-35. Brain, Behavior, and Immunity 108, pages 16-31.
Crossref
Crossref
Alexandre Chan, Ivy Cheng, Claire Wang, Chia Jie Tan, Yi Long Toh, Ding Quan Ng, Yong Qin Koh, Hanzhang Zhou, Koon Mian Foo, Raymond Javan Chan, Han Kiat Ho, Lita Chew, Mohamad Farid & Ian Tannock. (2022) Cognitive impairment in adolescent and young adult cancer patients: Pre‐treatment findings of a longitudinal study. Cancer Medicine 12:4, pages 4821-4831.
Crossref
Crossref
Kate R. Oppegaard, Terri S. Armstrong, Joaquin A. Anguera, Kord M. Kober, Debra Lynch Kelly, Rob C. Laister, Leorey N. Saligan, Ana Patricia Ayala, John Kuruvilla, Mark W. Alm, William H. Byker, Christine Miaskowski & Samantha J. Mayo. (2022) Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: A scoping review. Critical Reviews in Oncology/Hematology 180, pages 103822.
Crossref
Crossref
Haiyan Zhu, Fei Li, Yan Chang, Yabing Sun, Nan Wang & Ruimin Wang. (2022) Evaluation of the Effects of R-CHOP Chemotherapy on Brain Glucose Metabolism in Patients with Diffuse Large B Cell Lymphoma: A Baseline, Interim, and End-of-Treatment PET/CT Study. Tomography 8:5, pages 2565-2573.
Crossref
Crossref
Diane Von Ah, Brenna C. McDonald, Adele D. Crouch, Susan Ofner, Susan Perkins, Susan Storey, Robert Considine & Fred Unverzagt. (2022) Randomized double-masked controlled trial of cognitive training in breast cancer survivors: a preliminary study. Supportive Care in Cancer 30:9, pages 7457-7467.
Crossref
Crossref
Meltem TUNCER. (2022) Chemobrain: Mysteries and the importance of their revelation. Hacettepe University Journal of the Faculty of Pharmacy.
Crossref
Crossref
Ding Quan Ng, Daniella Chan, Parisa Agrawal, Weian Zhao, Xiangmin Xu, Munjal Acharya & Alexandre Chan. (2022) Evidence of brain-derived neurotrophic factor in ameliorating cancer-related cognitive impairment: A systematic review of human studies. Critical Reviews in Oncology/Hematology 176, pages 103748.
Crossref
Crossref
Michelle C Janelsins, Mostafa Mohamed, Luke J Peppone, Allison Magnuson, Elizabeth K Belcher, Marianne Melnik, Shaker Dakhil, Jodi Geer, Charles Kamen, Lori Minasian, Patrick M Reagan, Supriya G Mohile, Gary R Morrow, Tim A Ahles & Charles E Heckler. (2022) Longitudinal Changes in Cognitive Function in a Nationwide Cohort Study of Patients With Lymphoma Treated With Chemotherapy. JNCI: Journal of the National Cancer Institute 114:1, pages 47-59.
Crossref
Crossref
Ogün Bülbül, Sibel Göksel & Demet Nak. (2022) Changes in glucose metabolism of the brain after immunochemotherapy in patients with diffuse large B-Cell lymphoma on fluorodeoxyglucose positron emission tomography/computed tomography. Journal of Radiation and Cancer Research 0:0, pages 0.
Crossref
Crossref
Vanishree Rao, Rashmi Bhushan, Priyanka Kumari, Sri Pragnya Cheruku, V. Ravichandiran & Nitesh Kumar. 2022. Strategies to Mitigate the Toxicity of Cancer Therapeutics. Strategies to Mitigate the Toxicity of Cancer Therapeutics
29
76
.
Lori J. Bernstein, Kim Edelstein, Alisha Sharma & Claude Alain. (2021) Chemo-brain: An activation likelihood estimation meta-analysis of functional magnetic resonance imaging studies. Neuroscience & Biobehavioral Reviews 130, pages 314-325.
Crossref
Crossref
Delphine Puttaert, Vincent Wens, Patrick Fery, Antonin Rovai, Nicola Trotta, Nicolas Coquelet, Sandra De Breucker, Niloufar Sadeghi, Tim Coolen, Serge Goldman, Philippe Peigneux, Jean-Christophe Bier & Xavier De Tiège. (2021) Decreased Alpha Peak Frequency Is Linked to Episodic Memory Impairment in Pathological Aging. Frontiers in Aging Neuroscience 13.
Crossref
Crossref
Jung Kyung Hong, Hyuk Joo Lee, Seockhoon Chung & In-Young Yoon. (2021) Differences in sleep measures and waking electroencephalography of patients with insomnia according to age and sex. Journal of Clinical Sleep Medicine 17:6, pages 1175-1182.
Crossref
Crossref
Johanna Mariegaard, Jonathan Wenstrup, Kevin Zi Ming Lim, Pernille Envold Bidstrup, Annika von Heymann, Christoffer Johansen, Gitte Moos Knudsen, Ian Law, Lena Specht & Dea Siggaard Stenbæk. (2020) Prevalence of cognitive impairment and its relation to mental health in Danish lymphoma survivors. Supportive Care in Cancer 29:6, pages 3319-3328.
Crossref
Crossref
Jaidyn Muhandiramge, Suzanne Orchard, Andrew Haydon & John Zalcberg. (2021) The acceleration of ageing in older patients with cancer. Journal of Geriatric Oncology 12:3, pages 343-351.
Crossref
Crossref
Chenying Wang, Yuhang Zhao, Lewei Wang, Shunji Pan, Yumei Liu, Sanqiang Li & Dongmei Wang. (2020) C-phycocyanin Mitigates Cognitive Impairment in Doxorubicin-Induced Chemobrain: Impact on Neuroinflammation, Oxidative Stress, and Brain Mitochondrial and Synaptic Alterations. Neurochemical Research 46:2, pages 149-158.
Crossref
Crossref
Kester A. Phillips & David Schiff. 2021. Blood and Marrow Transplant Handbook. Blood and Marrow Transplant Handbook
593
622
.
Harvey R. Fernandez, Ashima Varma, Sarah A. Flowers & George William Rebeck. (2020) Cancer Chemotherapy Related Cognitive Impairment and the Impact of the Alzheimer’s Disease Risk Factor APOE. Cancers 12:12, pages 3842.
Crossref
Crossref
E. Mezenge, C. Pozuelos, G. Bouguet, L. Tron, F. Joly & M. Lange. (2021) Plainte cognitive à l’issue des traitements d’un lymphome. Psycho-Oncologie 14:4, pages 201-206.
Crossref
Crossref
Noha M. Mounier, Amany El-Shahawy Abdel-Maged, Sara A. Wahdan, Amany M. Gad & Samar S. Azab. (2020) Chemotherapy-induced cognitive impairment (CICI): An overview of etiology and pathogenesis. Life Sciences 258, pages 118071.
Crossref
Crossref
Sarah Eide & Zhong-Ping Feng. (2020) Doxorubicin chemotherapy-induced “chemo-brain”: Meta-analysis. European Journal of Pharmacology 881, pages 173078.
Crossref
Crossref
Lien D Nguyen & Barbara E Ehrlich. (2020) Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases. EMBO Molecular Medicine 12:6.
Crossref
Crossref
Sara Emad El-Agamy, Amal Kamal Abdel-Aziz, Ahmed Esmat & Samar S. Azab. (2019) Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain. Cancer Chemotherapy and Pharmacology 84:1, pages 1-14.
Crossref
Crossref
Knut B. Smeland, Jon H. Loge, Hans C. D. Aass, Trude Aspelin, Hanne Bersvendsen, Nils Bolstad, Unn-Merete Fagerli, Ragnhild S. Falk, Øystein Fluge, Alexander Fosså, Harald Holte, May B. Lund, Klaus Murbræch, Kristin V. Reinertsen, Jo S. Stenehjem & Cecilie E. Kiserud. (2018) Chronic fatigue is highly prevalent in survivors of autologous stem cell transplantation and associated with IL-6, neuroticism, cardiorespiratory fitness, and obesity. Bone Marrow Transplantation 54:4, pages 607-610.
Crossref
Crossref
D. R. Teregulova, B. A. Bakirov & L. R. Akhmadeeva. (2018) Influence of polychemotherapy on cognitive functions in patients with lymphoproliferative diseases: literature review and personal clinical observations. Perm Medical Journal 35:6, pages 73-81.
Crossref
Crossref
Claudio Festuccia, Andrea Mancini, Alessandro Colapietro, Giovanni Luca Gravina, Flora Vitale, Francesco Marampon, Simona Delle Monache, Simona Pompili, Loredana Cristiano, Antonella Vetuschi, Vincenzo Tombolini, Yi Chen & Thomas Mehrling. (2018) The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma. Journal of Hematology & Oncology 11:1.
Crossref
Crossref
David E. Anderson, Vijaya R. Bhatt, Kendra Schmid, Matthew Lunning, Sarah A. Holstein & Matthew Rizzo. (2018) Electrophysiological Measure of Impaired Information Processing in Drivers with Hematological Malignancy. Transportation Research Record: Journal of the Transportation Research Board 2672:37, pages 64-73.
Crossref
Crossref
Nicolas Aide, Thibault Salomon & Charline Lasnon. (2018) Reply to the Letter to the Editor from Peters et al: On the use of the liver as a reference organ for Deauville scoring in lymphoma patients and how it may be affected by liver steatosis. European Journal of Nuclear Medicine and Molecular Imaging 45:12, pages 2233-2234.
Crossref
Crossref
Louise Baussard, Marion Carayol, Bertrand Porro, Fanny Baguet & Florence Cousson-Gelie. (2018) Fatigue in cancer patients: Development and validation of a short form of the Multidimensional Fatigue Inventory (MFI-10). European Journal of Oncology Nursing 36, pages 62-67.
Crossref
Crossref
Dong-Dong Shi, Celia M. Dong, Leon C. Ho, C.T.W. Lam, Xi-Dan Zhou, Ed X. Wu, Zhong-Jun Zhou, Xiao-Min Wang & Zhang-Jin Zhang. (2018) Resveratrol, a natural polyphenol, prevents chemotherapy-induced cognitive impairment: Involvement of cytokine modulation and neuroprotection. Neurobiology of Disease 114, pages 164-173.
Crossref
Crossref
Hiroki Masuda, Masahiro Mori, Akiyuki Uzawa, Tomohiko Uchida, Ryohei Ohtani, Shigeo Kobayashi & Satoshi Kuwabara. (2018) Validation of the Modified Fatigue Impact Scale and the relationships among fatigue, pain and serum interleukin-6 levels in patients with neuromyelitis optica spectrum disorder. Journal of the Neurological Sciences 385, pages 64-68.
Crossref
Crossref
AnnaLynn M. Williams, Raven Shah, Michelle Shayne, Alissa J. Huston, Marcia Krebs, Nicole Murray, Bryan D. Thompson, Kassandra Doyle, Jenna Korotkin, Edwin van Wijngaarden, Sharon Hyland, Jan A. Moynihan, Deborah A. Cory-Slechta & Michelle C. Janelsins. (2018) Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy. Journal of Neuroimmunology 314, pages 17-23.
Crossref
Crossref
Julie K. Silver, Vishwa S. Raj & Eric M. Wisotzky. 2018. Quality Cancer Care. Quality Cancer Care
119
147
.
Sabino Ciavarella, Carla Minoia, Angela Maria Quinto, Stefano Oliva, Santa Carbonara, Claudia Cormio, Maria Christina Cox, Elena Bravo, Filippo Santoro, Mariarosaria Napolitano, Michele Spina, Giacomo Loseto & Attilio Guarini. (2017) Improving Provision of Care for Long-term Survivors of Lymphoma. Clinical Lymphoma Myeloma and Leukemia 17:12, pages e1-e9.
Crossref
Crossref
Milena Vitali, Carla Ida Ripamonti, Fausto Roila, Claudia Proto, Diego Signorelli, Martina Imbimbo, Giulia Corrao, Angela Brissa, Gallucci Rosaria, Filippo de Braud, Marina Chiara Garassino & Giuseppe Lo Russo. (2017) Cognitive impairment and chemotherapy: a brief overview. Critical Reviews in Oncology/Hematology 118, pages 7-14.
Crossref
Crossref
Theresa Currier Thomas, Joshua A. Beitchman, Francois Pomerleau, Teresa Noel, Paiboon Jungsuwadee, D. Allan Butterfield, Daret K. St. Clair, Mary Vore & Greg A. Gerhardt. (2017) Acute treatment with doxorubicin affects glutamate neurotransmission in the mouse frontal cortex and hippocampus. Brain Research 1672, pages 10-17.
Crossref
Crossref
Andreas Mierau, Wolfgang Klimesch & Jérémie Lefebvre. (2017) State-dependent alpha peak frequency shifts: Experimental evidence, potential mechanisms and functional implications. Neuroscience 360, pages 146-154.
Crossref
Crossref
Dorothy Krolak, Barbara Collins, Lorelle Weiss, Cheryl Harris & Richard Van der Jagt. (2016) Cognitive function and its relationship to other psychosocial factors in lymphoma survivors. Supportive Care in Cancer 25:3, pages 905-913.
Crossref
Crossref
Mohd Ashif Khan, Kamlesh Garg, Dinesh Bhurani & Nidhi Bharal Agarwal. (2016) Early manifestation of mild cognitive impairment in B-cell non-Hodgkin’s lymphoma patients receiving CHOP and rituximab-CHOP chemotherapy. Naunyn-Schmiedeberg's Archives of Pharmacology 389:12, pages 1253-1265.
Crossref
Crossref
Jéssica Ramos Pereira, Lílian Viana dos Santos, Renata Maria Silva Santos, Ana Luíza Figueiredo Campos, André Lana Pimenta, Mateus Silva de Oliveira, Geander Gaburro Bacheti, Natália Pessoa Rocha, Antônio Lúcio Teixeira, Paulo Pereira Christo & Paula Luciana Scalzo. (2016) IL-6 serum levels are elevated in Parkinson's disease patients with fatigue compared to patients without fatigue. Journal of the Neurological Sciences 370, pages 153-156.
Crossref
Crossref
Annalynn M. Williams, Clive S. Zent & Michelle C. Janelsins. (2016) What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research. British Journal of Haematology 174:6, pages 835-846.
Crossref
Crossref
Ilhan Lim, Hye-Young Joung, A Ram Yu, Insop Shim & Jin Su Kim. (2016) PET Evidence of the Effect of Donepezil on Cognitive Performance in an Animal Model of Chemobrain. BioMed Research International 2016, pages 1-7.
Crossref
Crossref
Alessandra Suuberg. (2018) Mechanisms and Treatment of Chemotherapy-Induced Cognitive Impairment ('Chemobrain'). SSRN Electronic Journal.
Crossref
Crossref